Found: 110
Select item for more details and to access through your institution.
Correction to: Clinical management of ageing people living with HIV in Europe: the view of the care providers.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Clinical management of ageing people living with HIV in Europe: the view of the care providers.
- Published in:
- Infection, 2020, v. 48, n. 4, p. 497, doi. 10.1007/s15010-020-01406-7
- By:
- Publication type:
- Article
Pharmacological impact of antiretroviral therapy on platelet function to investigate human immunodeficiency virus-associated cardiovascular risk.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Iatrogenic Cushing's syndrome due to drug interaction between glucocorticoids and the ritonavir or cobicistat containing HIV therapies.
- Published in:
- Clinical Medicine, 2016, v. 16, n. 5, p. 412, doi. 10.7861/clinmedicine.16-5-412
- By:
- Publication type:
- Article
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. 398, doi. 10.1093/cid/ciac803
- By:
- Publication type:
- Article
Infectious Proctitis due to Human Mpox.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e1424, doi. 10.1093/cid/ciac713
- By:
- Publication type:
- Article
Strengths and Challenges of Various Models of Geriatric Consultation for Older Adults Living With Human Immunodeficiency Virus.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1101, doi. 10.1093/cid/ciab682
- By:
- Publication type:
- Article
Indirect Human Immunodeficiency Virus Morbidity and Mortality Due to Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 10, p. 1947, doi. 10.1093/cid/ciab128
- By:
- Publication type:
- Article
Pharmacokinetics of Efavirenz 400 mg Once Daily Coadministered With Isoniazid and Rifampicin in Human Immunodeficiency Virus–Infected Individuals.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 3, p. 446, doi. 10.1093/cid/ciy491
- By:
- Publication type:
- Article
Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 1, p. 87, doi. 10.1093/cid/ciy426
- By:
- Publication type:
- Article
Episodic disability questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United States.
- Published in:
- BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-023-08958-7
- By:
- Publication type:
- Article
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts.
- Published in:
- HIV Medicine, 2024, v. 25, n. 4, p. 440, doi. 10.1111/hiv.13593
- By:
- Publication type:
- Article
Anticholinergic medications associated with falls and frailty in people with HIV.
- Published in:
- HIV Medicine, 2023, v. 24, n. 12, p. 1198, doi. 10.1111/hiv.13532
- By:
- Publication type:
- Article
BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022.
- Published in:
- HIV Medicine, 2022, v. 23, p. 3, doi. 10.1111/hiv.13446
- By:
- Publication type:
- Article
UK guideline for the use of HIV post‐exposure prophylaxis 2021.
- Published in:
- HIV Medicine, 2022, v. 23, n. 5, p. 494, doi. 10.1111/hiv.13208
- By:
- Publication type:
- Article
FRAX assessment in people ageing with HIV.
- Published in:
- HIV Medicine, 2022, v. 23, n. 1, p. 103, doi. 10.1111/hiv.13170
- By:
- Publication type:
- Article
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIV.
- Published in:
- HIV Medicine, 2021, v. 22, n. 9, p. 816, doi. 10.1111/hiv.13137
- By:
- Publication type:
- Article
Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort.
- Published in:
- HIV Medicine, 2020, v. 21, n. 9, p. 613, doi. 10.1111/hiv.12900
- By:
- Publication type:
- Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
- Published in:
- HIV Medicine, 2016, v. 17, p. s2, doi. 10.1111/hiv.12426
- By:
- Publication type:
- Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.).
- Published in:
- HIV Medicine, 2014, v. 15, p. 1, doi. 10.1111/hiv.12119
- By:
- Publication type:
- Article
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.
- Published in:
- HIV Medicine, 2012, v. 13, p. 1, doi. 10.1111/j.1468-1293.2012.01029.x
- By:
- Publication type:
- Article
British HIV Association guidelines For the treatment of H1V-1-positive adults with antiretroviral therapy 2012.
- Published in:
- HIV Medicine, 2012, v. 13, p. 1
- By:
- Publication type:
- Article
Changes in functional connectivity in people with HIV switching antiretroviral therapy.
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 5, p. 754, doi. 10.1007/s13365-020-00853-0
- By:
- Publication type:
- Article
Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults.
- Published in:
- Chemotherapy Research & Practice, 2011, p. 1, doi. 10.1155/2011/393976
- By:
- Publication type:
- Article
Prevalence, severity, and risk factors of disability among adults living with HIV accessing routine outpatient HIV care in London, United Kingdom (UK): A cross-sectional self-report study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0267271
- By:
- Publication type:
- Article
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0253861
- By:
- Publication type:
- Article
Prevention of atherosclerosis in patients living with HIV.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Prevention of atherosclerosis in patients living with HIV.
- Published in:
- Vascular Health & Risk Management, 2009, v. 5, p. 287
- By:
- Publication type:
- Article
Antiviral Activity, Safety, and Exposure–Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002).
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 3, p. 442, doi. 10.1093/cid/cix239
- By:
- Publication type:
- Article
Pharmacology Lessons From Chemoprophylaxis Studies.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. suppl_1, p. S52, doi. 10.1093/cid/ciu250
- By:
- Publication type:
- Article
Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4-Tropic HIV Type 1.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 6, p. 798, doi. 10.1086/597097
- By:
- Publication type:
- Article
Changes in multimorbidity burden over a 3-5 year period among people with HIV.
- Published in:
- Frontiers in Systems Biology, 2023, v. 3, p. 1, doi. 10.3389/fsysb.2023.1136999
- By:
- Publication type:
- Article
Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Study.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa561
- By:
- Publication type:
- Article
A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 2, p. N.PAG, doi. 10.1093/ofid/ofz035
- By:
- Publication type:
- Article
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine.
- Published in:
- Therapeutic Advances in Infectious Disease, 2023, v. 10, p. 1, doi. 10.1177/20499361231214626
- By:
- Publication type:
- Article
New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
The predictive role of symptoms in COVID-19 diagnostic models: A longitudinal insight.
- Published in:
- Epidemiology & Infection, 2024, v. 152, p. 1, doi. 10.1017/S0950268824000037
- By:
- Publication type:
- Article
Raltegravir switch improves hepatitis Ctransaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals.
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Results of a Multi-Disciplinary Approach Involving Geriatricians of a Clinic for Older People Living with HIV.
- Published in:
- AIDS Patient Care & STDs, 2023, v. 37, n. 5, p. 213, doi. 10.1089/apc.2023.0011
- By:
- Publication type:
- Article
Effects of the H<sub>2</sub>-Receptor Antagonist Famotidine on the Pharmacokinetics of Atazanavir-Ritonavir With or Without Tenofovir in HIV-Infected Patients.
- Published in:
- AIDS Patient Care & STDs, 2011, v. 25, n. 9, p. 509, doi. 10.1089/apc.2011.0113
- By:
- Publication type:
- Article
Effects of Different Meal Compositions and Fasted State on the Oral Bioavailability of Etravirine.
- Published in:
- Pharmacotherapy, 2008, v. 28, n. 10, p. 1215
- By:
- Publication type:
- Article
Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Pharmacokinetics of the co-administration of boceprevir and St John's wort to male and female healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 7, p. 1911, doi. 10.1093/jac/dku060
- By:
- Publication type:
- Article
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 4, p. 885, doi. 10.1093/jac/dkq546
- By:
- Publication type:
- Article
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 180, doi. 10.1093/jac/dkq411
- By:
- Publication type:
- Article
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 6, p. 1233, doi. 10.1093/jac/dkp102
- By:
- Publication type:
- Article
Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 6, p. 1344, doi. 10.1093/jac/dkn399
- By:
- Publication type:
- Article
Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 161, doi. 10.1093/jac/dkn187
- By:
- Publication type:
- Article